8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine
C90H89BBrCl3F6N24O8 — CID 158280318
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine
8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine (PubChem CID 158280318) has the molecular formula C90H89BBrCl3F6N24O8 and a molecular weight of 1945.92 g/mol. Its IUPAC name is 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine.
Molecular Properties
| Compound Name | 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine |
|---|---|
| PubChem CID | 158280318 |
| Molecular Formula | C90H89BBrCl3F6N24O8 |
| Molecular Weight | 1945.92 g/mol |
| Exact Mass | 1942.55 |
| IUPAC Name | 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine |
| SMILES | C1=CN=C(C2CNCCO2)C1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1B1OC(C)(C)C(C)(C)O1.Clc1cc(Br)c2nccn2n1.Clc1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1.Clc1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1 |
| InChI | InChI=1S/C28H24F3N7O2.C20H22BF3N2O3.2C14H14ClN5O.C8H12N2O.C6H3BrClN3/c1-17-21(13-20(15-34-17)35-27(39)18-4-2-5-19(12-18)28(29,30)31)23-14-24(26-33-8-9-38(26)36-23)37-10-11-40-25(16-37)22-6-3-7-32-22;1-12-16(21-28-18(2,3)19(4,5)29-21)10-15(11-25-12)26-17(27)13-7-6-8-14(9-13)20(22,23)24;2*15-13-8-11(14-17-4-5-20(14)18-13)19-6-7-21-12(9-19)10-2-1-3-16-10;1-2-7(10-3-1)8-6-9-4-5-11-8;7-4-3-5(8)10-11-2-1-9-6(4)11/h2-5,7-9,12-15,25H,6,10-11,16H2,1H3,(H,35,39);6-11H,1-5H3,(H,26,27);2*1,3-5,8,12H,2,6-7,9H2;1,3,8-9H,2,4-6H2;1-3H |
| InChIKey | GKDBKWNZXYFCSV-UHFFFAOYSA-N |
| XLogP | 15.27 |
| TPSA | 331.31 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 133 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1945.92 |
| LogP ≤ 5 | 15.27 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 30 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158280318 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.